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T
he First Conference on Menthol Cigarettes was
convened in Atlanta, Georgia, on March 21 and
22, 2002.† The purpose of the conference was to
evaluate the present state of the science concerning the
health implications of adding menthol to cigarettes,
and to set the priorities for further studies on health
effects of menthol cigarettes. The conference sponsors
will make the conference proceedings available to a
wider audience through a supplemental issue to be
published with Nicotine & Tobacco
Research journal in early 2004. This
Executive Summary presents back-
ground on use of menthol in cigarettes
and summarizes the topics that will be
discussed in the supplemental issue.
Special thanks go to Pamela I.
Clark, Ph.D., Phillip S. Gardiner,
Dr.P.H., Mirjana V. Djordjevic, Ph.D.,
Scott J. Leischow, Ph.D., and Robert
G. Robinson, Dr.P.H., for taking the lead in 
developing this Executive Summary.
Introduction
Menthol is unique in that it is the only cigarette 
additive that is actively marketed to consumers. It is
the only aspect of cigarette design that is explicitly
marketed based on its physiological effects, as an 
anti-irritant and a cooling agent. It is the only 
cigarette additive about which consumers make 
conscious buying choices. 
While the tobacco industry has actively investi-
gated menthol as an additive,1,2,3,4,5,6 there have been
relatively few studies in the public health literature
about:
■ the emergence of menthol cigarettes;
■ the use of menthol cigarettes by some segments of
the smoking population;
■ the targeted marketing of menthol cigarettes to
specific population groups;
■ reported reasons for menthol cigarette use;
■ the addictive, physiological, and toxicological
properties of menthol cigarettes, which are pur-
portedly different from nonmentholated brands;
■ the potential of menthol cigarettes to increase
exposure to harmful smoke constituents; 
■ the propensity of menthol cigarettes to aid in the
initiation of smoking among adolescents; and  
■ the impact of mentholated cigarettes
on smoking-related disease, disability, and
death. 
Investigating the issues related to
adding menthol to cigarettes will not 
only contribute to the knowledge about
menthol’s role in the initiation and 
progression of tobacco use, but will also
aid in a better understanding of its effect
on addiction to cigarettes and the rate of
smoking-related diseases. New research also can lead
to development of models to study the health impact
of other cigarette additives and cigarette designs,
including emerging potential reduced-exposure 
tobacco products. 
The emergence of menthol 
cigarettes
Menthol cigarettes were conceived as specialty prod-
ucts in the 1920s and 1930s.3 These cigarettes were
initially marketed as a luxury product, through radio
and magazine ads, and especially targeted to women
smokers.7 Until the 1960s, the market share of men-
thol cigarettes never exceeded 5 percent.7 However,
with the great migration of African Americans from
the South to urban centers, peaking during and after
World War II, the industry started targeting menthol
cigarettes to African Americans. Launched in the early
1940s, the popular African American magazines (e.g.,
Ebony, Jet)8 offered a unique opportunity for precision
marketing. By the 1960s and 1970s, menthol brands
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had become the cigarettes of choice for the majority of
African American smokers.7,9,10 Whereas only about 25
percent of White smokers use menthol cigarettes,
more than 70 percent of African American smokers
choose them; other population segments are now
adopting menthol use, including young people, Asian
and Pacific Islander Americans, and women.11 Today,
menthol cigarettes represent about 26 percent of all
cigarettes sold in the United States.12 Newport ciga-
rettes are the leading menthol brand and are second
only to Marlboro in overall market share. 
Why it is important to study 
menthol cigarettes 
One urgent question that needs to be answered is
whether menthol cigarettes contribute to the health
disparities between White and African American
smokers. Although African Americans tend to 
smoke fewer cigarettes per day than do White 
smokers,9,13,14,15,16 incidence and 
mortality rates of lung cancer and
other smoking-related diseases are
significantly higher among African
Americans. For example, average
age-adjusted annual incidence rates
for lung cancer in the United States
between 1992 and 1998 were
54.7/100,000 for Whites and
71.6/100,000 for African
Americans; mortality rates, for the
same period, were 48.8 for Whites
and 59.1 for African Americans.17
Historically, the age-adjusted 
smoking-related lung cancer death
rates in the United States among African American
males and White males were: in 1950, 15.7 and 21.9,
respectively; in 1965, 47.8 and 47.3, respectively; and
in 1990, 107.7 and 73.6, respectively. Whether these
trends reflect the trends of use of menthol cigarettes
by African Americans remains to be determined.18
Menthol, a chemical compound extracted from
the peppermint plant and classified as a mild local
anesthetic, was commonly used in veterinary medi-
cine.19 Colorless and with a mint scent, menthol was
first added to cigarettes in the 1920s and 1930s to
mask the harshness of tobacco smoke.3 Fifty-two per-
cent of 174 African Americans interviewed in one
study reported that mentholated cigarettes were less
harsh on the throat, 48 percent stated that inhalation
was easier, and 33 percent felt they could inhale more
deeply.20
Since the 1960s, menthol brands have been mar-
keted by the industry as “refreshing” and “cool.”19
Menthol stimulates cold receptors, with the resulting
sensation of coolness perceived not only in the mouth
and pharynx, but also in the lungs.21,22 Stimulation of
laryngeal cold receptors may reduce airway irritation.23
This sensation of coolness might result in deeper
inhalation, but because of the difficulty in precisely
measuring the inhalation phase of smoking, this issue
has not been adequately studied. Menthol may increase
salivary flow thereby enhancing the passage of harmful
smoke constituents across mucus membranes.24,25
Menthol has been shown to increase significantly
involuntary breath holding.26 Breath
holding at peak inspiration could
contribute to increased uptake of
inhaled tobacco smoke constituents,
including nicotine and cancer-
causing agents, from the alveoli of
the lungs into the bloodstream.
There have been conflicting reports
on the effect of menthol on smoking
topography (e.g., puff volume, puff
frequency) that may be due to small
samples and variations in study pop-
ulations.15,27 The 1999 Massachusetts
Benchmark Study of the 24 most
popular U.S. filter cigarette brands
and styles (six of them were menthol brands) provided
some evidence that the chemical composition of the
mainstream smoke of selected menthol cigarettes 
differs from that of their nonmenthol counterparts.28
The yields of “tar,” nicotine, carbon monoxide, and
several carcinogenic compounds (e.g., benzene, 1,3-
butadiene, benzo[a]pyrene, NNK), obtained by the
Massachusetts machine-smoking method, were 
30-70 percent higher in the mainstream smoke of
menthol cigarettes than in the smoke of the selected
2
Although African Americans
tend to smoke fewer 
cigarettes per day than do
White smokers, incidence
and mortality rates of lung
cancer and other smoking-
related diseases are 
significantly higher among
African Americans.
nonmentholated brands. There are many cigarette
design characteristics (e.g., tobacco blend, resistance to
draw, paper porosity, amount of tobacco in the rod,
cigarette length, and others) that may contribute to
differences in yield that are independent of menthola-
tion. For example, Newport, the most popular men-
thol brand in the United States, is a “full flavor” 
cigarette with no filter ventilation holes, while the
most popular nonmentholated brand, “full flavor”
Marlboro, averages 8 percent ventilation in the hard
pack version and 11 percent ventilation in the soft
pack.28
Emerging research on behavior,
epidemiology, and toxicology of
menthol cigarettes 
The tobacco industry and some
members of the scientific community
studied the effects of menthol on
human tissue when menthol was first
introduced into cigarettes. In 1944,
Brown & Williamson commissioned
a literature search on the toxic effects
of menthol.29 Thus, the industry
knew early on that menthol, when
tested on animals, had distinct prop-
erties that had to be accounted for in
the delivery of nicotine to cigarette
smokers. 
Although the industry had an early interest in the
use and effects of menthol added to cigarettes, the
public health community was not conducting exten-
sive menthol-related research. Studies of the effects of
smoking menthol cigarettes are now emerging. In
1989, the first epidemiological study of health effects
of smoking menthol cigarettes was published,30 and
there have since been several others.14,31,32,33,34,35 To date,
epidemiological studies of the relationship between
smoking menthol cigarettes and cancer risk have
shown mixed results, and have been limited by 
problems such as too few subjects exclusively smoking
menthol cigarettes for too short a time. Little is
known about the brand- and style-switching habits 
of smokers, so classifying subjects as exclusively 
menthol or nonmenthol smokers for a long enough
time period is difficult. For instance, it is not known 
if the “worried well” may switch to menthol cigarettes
because they perceive them to be less harmful or if
subjects with a persistent cough may switch to a men-
tholated brand for its local anesthetic and cooling
properties. Both aspects may cause a misclassification
bias of unknown magnitude in epidemiological stud-
ies. Also, the increased “dose” delivered with menthol
cigarettes may be no more than the equivalent of a
few cigarettes a day among heavy smokers, or even a
single extra cigarette among lighter smokers (which
African American smokers generally are). Thus, pars-
ing out the additional harm associated with smoking
menthol cigarettes might require very large sample
sizes or the exclusive use of menthol
cigarettes for long periods. No stud-
ies have been reported on the effect
of menthol cigarettes on noncancer
health outcomes, such as nicotine
addiction, cardiovascular disease,
chronic obstructive pulmonary 
disease, and birth outcome. 
The comparative studies of the
uptake of smoke constituents, includ-
ing nicotine and carcinogens, among
smokers of menthol and nonmenthol
cigarettes, as determined by measur-
ing the levels of biological markers,
are now emerging.15,36,37,38 One study
reported that the levels of urinary 1-hydroxyperene 
(a marker of polycyclic aromatic hydrocarbon [PAH]
exposure) per cigarette smoked by male menthol
smokers were about 2.7-fold higher than the levels
measured among nonmenthol cigarette smokers based
on equimolar benzo(a)pyrene dosage delivered in the
mainstream smoke. The latter observation suggested
that menthol may enhance the uptake of PAH from
mainstream smoke and alter metabolism, or that racial
differences in the metabolic activation of carcinogens
are factors in uptake and metabolism of PAH.37 The
absence of a crossover component, in which subjects
are tested while smoking both menthol and nonmenthol
styles, has been a significant limitation in the 
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interpretation of some studies. Thus, it is not known
if the results were attributable to interaction between
individual differences in smoking (such as inhalation
or breath-holding patterns), addiction and disease sus-
ceptibility, and the preference for menthol cigarettes,
rather than menthol smoking per se. This is an impor-
tant distinction given that cigarette smoking is a highly
ritualistic activity developed, in part, to maintain a
physiologically needed level of blood nicotine.
Crossover designs will help separate individual idio-
syncratic smoking patterns from those attributable to
smoking menthol cigarettes. Direct measures of body
burdens of carcinogens are required to better under-
stand the relative harm of menthol
and nonmenthol cigarettes. These
studies are beginning to emerge.15
Studies of the epidemiology
and toxicology of menthol ciga-
rettes and behavioral issues
involved in their use are beginning
to receive appropriate attention.
Significant gaps in knowledge per-
sist, however. The First Conference
on Menthol Cigarettes was con-
vened to summarize what we know,
what we suspect, and to state the
research priorities. The following
section provides a brief description




Proceedings of The First Conference on Menthol
Cigarettes: Setting the Research Agenda will be pub-
lished in a peer-reviewed supplemental issue to the
journal Nicotine & Tobacco Research in early 2004, 
and also will be available via the National Cancer
Institute’s Web site at http://dccps.nci.nih.gov/
TCRB/ (accessed August 27, 2003). The supplemental
issue will cover the current state of knowledge on 
marketing, history, social factors, pharmacology, 
epidemiology, and toxicology of menthol cigarette 
use. Following is a brief description of the contents 
of the papers summarizing this conference. 
The African Americanization of
Menthol Cigarette Use in the
United States
Phillip S. Gardiner, Dr.P.H.
Today, more than 70 percent of African American
smokers prefer menthol cigarettes as compared to 
30 percent of White smokers. This unique social 
phenomenon was occasioned principally by the tobacco
industry’s masterful manipulation of the burgeoning
African American, urban, segregated, consumer market
in the 1960s. Through the use of television and other
advertising media, coupled with culturally tailored
images and messages, the tobacco
industry “African Americanized”
menthol cigarettes. The tobacco
industry successfully positioned
mentholated products, especially
Kool, as young, hip, new, and
healthy. During the time that 
menthol cigarettes gained a large
market share in the African
American community, the tobacco
industry donated funds to African
American organizations hoping to
blunt the attack on its products.
Many of the findings in this
article are drawn from the tobacco
industry documents disclosed fol-
lowing the Master Settlement
Agreement in 1998. This article
examines some key social factors
that, when considered together, led to disproportion-
ate use of mentholated cigarettes by African Americans
as compared to other Americans. Unfortunately, the
long-term impact of the tobacco industry’s practice in
this community may be responsible, in part, for the
disproportionately high tobacco-related disease and
mortality among African Americans generally and
African American males particularly.
Numerous outstanding questions remain, 
including:
■ Did the tobacco industry know of any additional
adverse health effects that may result from adding
menthol to cigarettes?
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■ Why did the industry select
African Americans for targeting
of menthol cigarettes?  
■ Why has the use of mentholated
cigarettes reached a plateau of
about 25 percent of the U.S.
market?
■ Why is it that people living in
the Philippines, Cameroon, and
Hong Kong have high rates of
menthol cigarette use?  
The Marketing of Menthol
Cigarettes in the United States:
Populations, Messages, and
Channels
Charyn D. Sutton, B.A., and 
Robert G. Robinson, Dr.P.H.
Much of what is currently known about menthol ciga-
rettes concerns African Americans, a population that is
characterized by a preference for menthol cigarette
brands. Yet other ethnic minority groups, as well as
women and youth, have received their share of
unwanted attention from the manufacturers and mar-
keters of menthol cigarette brands.
There was a five-fold increase in menthol sales
from the 1950s through the 1980s. Three freestanding
menthol brands–Kool, Salem, and Newport–accounted
for nearly two-thirds of all menthol cigarette market
share in the United States during that period and
since. Four distinct advertising messages have been
central in the marketing of mentholated cigarettes as
an entire “coolness” category and as specific brands:
health, freshness, ethnic awareness (focusing on
African Americans), and youthful fun, bordering 
on silliness. These messages have been promoted
through targeted media to reach particular population
segments.  
The messages used to market menthol cigarettes
also have interacted with a product focus that demon-
strates a relationship between the level of menthol in
cigarettes and the effectiveness in retaining current
smokers (those who tend to prefer more menthol in
their cigarette brands), as well as recruiting new 
smokers (those whose initial attrac-
tion is generally to brands with
lower levels of menthol). Since 
individual brand preferences tend
to be locked in fairly early in life,
the menthol brand that can capture
teenagers and young adults invari-
ably becomes the next market
leader. Brands with more menthol
taste watched sales fall and market
share shrink as their customer 
base aged. 
Many questions remain unanswered in under-
standing the role of marketing in recruiting new
smokers for mentholated tobacco products and in
retaining existing smokers by making it more difficult
to quit. 
■ Are other population segments being steered
toward menthol cigarettes using marketing
approaches based on gender, race/ethnicity, age,
sexual orientation, cultural background, state, or
other demographics in ways that are similar to
what has occurred with African Americans? 
■ Is there any relationship between the marketing
and subsequent use of mentholated tobacco prod-
ucts by population subgroups and tobacco-related
health consequences? 
■ Are there lessons to be learned from the marketing
of menthol cigarettes that can be used to improve
the public health and medical communities’ 
marketing of smoking cessation and tobacco 
use prevention?
For too long, the public health community has
given only a cursory glance to the mentholated 
tobacco category, the ways by which it has been 
marketed to vulnerable and at-risk populations, and
the characteristics of the affected racial, ethnic, gender,
and other groups. The availability of internal industry 
documents and of new data from surveys that now ask
about menthol brand smoking provide us with an
opportunity to find answers to many of our questions.
Learning more about the messages and media that 
are used to promote mentholated cigarette brands to
target markets such as women, African Americans, and
multicultural youth can be an invaluable aid in help-
ing to decrease the uptake of menthol cigarette brands
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and in creating improved prevention and cessation
strategies for at-risk communities and populations.  
Physiological, Psychological,
Social, and Cultural Influences on
the Use of Menthol Cigarettes
Among African Americans and
Hispanics
Felipe Gonzalez Castro, Ph.D., M.S.W.
Evidence from various sources has revealed an unex-
plained association between racial/ethnic background
as African American or Hispanic and the use of men-
thol cigarettes. It has been postulated that marketing
practices have identified and exploited existing health-
related cultural beliefs and practices within the African
American and Hispanic communities to encourage the
use of menthol cigarettes. Ethnic-cultural associations
of menthol with wellness and recovery from illness
may have been used to promote the belief that men-
thol cigarettes are less toxic than nonmentholated 
cigarettes. 
Results from the available
research shows that beliefs regard-
ing the soothing-cooling and
health-enhancing effects of 
menthol are prevalent among
African Americans and Hispanics,
especially within lower-income 
sectors of these communities.
Epidemiological studies confirm
the higher rates of menthol 
cigarette use among African
Americans and Hispanics, relative
to non-Hispanic Whites. An 
unresolved question is:
■ To what extent are the higher
prevalence rates of mentholated cigarettes prefer-
ence/use among specific ethnic groups influenced
by social, cultural, or genetic/physiological factors?
It is likely that several of these factors operate in
combination to exert a synergistic effect on the
occurrence of these higher prevalence rates.
Epidemiology of Menthol 
Cigarette Use
Gary A. Giovino, Ph.D., M.S.; Stephen Sidney,
M.D., M.P.H.; Joseph C. Gfroerer, M.S.; Patrick
M. O’Malley, Ph.D.; Jane E. Allen, M.A.; Patricia
A. Richter, Ph.D.; and K. Michael Cummings,
Ph.D., M.P.H. 
Previously published work documented common use
of menthol cigarettes among African-American smok-
ers, both adolescents and adults. The literature was
summarized on menthol and cancer, FTC reports on
menthol brands, international market share data on
menthol market share, and national survey data on use
patterns among smokers.
The epidemiological literature to date does not
indicate that menthol cigarettes confer a risk for can-
cer above that from nonmentholated brands. Rather,
menthol cigarettes appear to be as hazardous as non-
menthol brands. About one-fourth of all cigarettes
sold in the United States are mentholated. There is
substantial international variability in menthol market
share, with the Philippines highest at 60 percent.
Among smokers in all racial/ethnic
groups, African Americans had the
highest prevalence of menthol ciga-
rette use. Among adolescent smok-
ers, Asian and Pacific Islander
Americans also had high menthol
use rates. Among those less than 26
years old, smokers of “full flavor”
cigarettes were more likely to smoke
menthol brands than were smokers
of “light” or “ultra-light” cigarettes.
Menthol smoking was more com-
mon in the Northeast than in the
West. The only sex difference
observed was in Whites aged 26
years and older, where women were more likely than
men to smoke mentholated cigarettes.
There are significant knowledge gaps, including
■ the need for more and better studies on menthol
and cancer of various sites, and the effect of men-
thol cigarettes on cardiovascular diseases;
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sectors of these communities.
■ the role of health beliefs on menthol use is not
known, nor is the effect of such beliefs on brand
selection; 
■ the reasons for the large international variation in
menthol use are not known (e.g., high rates in the
Philippines, generally lower
rates in African countries than
in African Americans);
■ further monitoring and study
of use of “cross-brands” such
as Marlboro Menthol and
Newport nonmenthol are
needed;
■ the association between use of
menthol cigarettes and illicit
drugs needs to be investigated; and 
■ the best way to measure menthol use in large
national surveys must be explored.
Menthol Pharmacology and Its
Potential Impact on Cigarette
Smoking Behavior
Karen Ahijevych, Ph.D., and 
Bridgette E. Garrett, Ph.D. 
There is a considerable body of research that has
examined the effects of menthol as a nontobacco addi-
tive. However, the effects of menthol in cigarette
smoke are more complex since it is administered to
the user in a matrix of more than 4,000 other sub-
stances. Therefore, isolation of the unique contribu-
tions of menthol to cigarette smoking behavior is
more difficult. Menthol properties include “cooling”
and local anesthesia, as well as effects on drug absorp-
tion, bronchodilation and respiration changes, electro-
physiology, and modified metabolism. Subjective
effects of smoothness and less harshness have been
identified as an impact of menthol on cigarette-
smoking behavior, and there have been inconclusive
findings regarding carbon monoxide exposure and
smoking topography parameters. Gaps in the research
literature and the questions that future research needs
to answer include: 
■ What is the role of menthol in tobacco reinforce-
ment and addiction?  
■ In the absence of nicotine, is menthol reinforcing?  
■ Are menthol’s pharmacological and physiological
effects mediated by a menthol-specific receptor or
some other central nervous system-mediated
action?  
■ What are the influences of men-
thol and menthol metabolism
related to metabolic activation
and detoxification of carcinogens
of tobacco smoking?  
■ Are there differences in cigarette
smoking in relation to the inter-
action of ethnicity, gender, and
menthol cigarette preference?  
Answers to these questions will
help to elucidate the function of menthol in cigarettes
and its impact on smoking behavior. 
Application, Use, and Effects of
Menthol in Cigarettes: A Survey of
Tobacco Industry Documents
Geoffrey Ferris Wayne, M.A., and 
Gregory N. Connolly, D.M.D, M.P.H.
Internal tobacco industry documents provide a valu-
able insight into industry knowledge of menthol’s
function and effects. In this chapter, the internal
industry research describing the role of menthol in
cigarette product design, including menthol applica-
tion and smoke delivery, physiological and respiratory
effects, and toxicological effects is reviewed. Industry
documents confirm the importance of menthol in
shaping smoker perception. Of particular importance
is menthol’s ability to reduce the harshness of cigarette
smoke, facilitating smoke intake, and to substitute for
nicotine “impact” perception in lower nicotine-yield
cigarettes. Other issues addressed in internal studies
include anesthetic and “cooling” effects, altered respi-
ratory perception, and increased respiratory irritation
and biological effects. Based on studying tobacco
industry documents, it is clear that the unique charac-
teristics of menthol cigarettes must be considered in
future research, cessation treatment, and enactment of
tobacco product regulations. The glimpse into the
industry’s research provides only a starting point in
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evaluating the effects and function of menthol in ciga-
rettes. Industry-funded studies should be replicated
and the results should be subjected to rigorous peer-
review, which is missing from most
of the industry research. 
Further studies are needed to 
understand:
■ the effects of menthol on the
central nervous system and
brain; 
■ the interaction of menthol with
perception of nicotine delivery,
including differences in regular
versus low-yield cigarettes; and 
■ long-term studies to assess the
biological effects of chronic
exposure to menthol inhalation.
Menthol Cigarettes: Research
Needs and Challenges
Jack E. Henningfield, Ph.D., and 
Mirjana V. Djordjevic, Ph.D.
The First Conference on Menthol Cigarettes: Setting
the Research Agenda provided a forum for discussion
of the origins, uses, and consequences of adding men-
thol to cigarettes. A major purpose of the conference
was to identify knowledge gaps in this area and to set
an agenda for research that would lay the foundation
for improving public health by reducing tobacco-
caused disease. The conference planning process 
made evident the many potential ways
that addition of menthol to cigarettes
may have contributed to tobacco-
attributable morbidity, disability, and
mortality. Thus, scientists representing
this diversity were invited to present
papers and participate in discussions
in order to evaluate thoroughly the
state of knowledge and the needs for
research. The papers featured in the
upcoming supplemental issue of the
Nicotine & Tobacco Research journal
provide the basis for drawing general
conclusions about the potential role of
menthol in cigarettes and disease, and
these conclusions have implications
for public health interventions. Equally important, the
papers identify major gaps in knowledge that stand as
barriers to tobacco disease control. Addressing the
research needs and challenges implied by these knowl-
edge gaps could contribute significantly to improved
public health.
This paper summarizes research needs and chal-
lenges that were discussed at the conference, as well as
several others that emerged as the presenters prepared
their papers for publication in this volume. 
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